<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Onyx Software | Company News & Executive Profiles | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/onyx+software.html?i=13]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Onyx Software]]></description>
	<s:counts start="0" returned="10" found="533" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Onyx strikes $811M deal to buy Proteolix]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/onyx-strikes-811m-buy-proteolix/15328/]]></link>
		<description><![CDATA[ Onyx Pharmaceuticals  ONXX  has struck a deal to buy the cancer drug developer  Proteolix  for $276 million down and up to $535 million more for development and regulatory milestones. Included in the prospective payments is a whopping $170 million for the accelerated approval of its lead...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Mon, 12 Oct 2009 05:29:48 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/onyx+software.html"><![CDATA[Onyx Software]]></category>
	</item>
	<item>
		<title><![CDATA[Bayer to Onyx: You Don't Even Know the Name of the Drug We Didn't Steal From You]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004575/bayer-to-onyx-you-dont-even-know-the-right-name-of-the-drug-we-didnt-steal-from-you/]]></link>
		<description><![CDATA[Bayer is arguing that it did not steal an analog of its Nexavar cancer drug from development partner Onyx because Onyx got the name of the analog wrong in its lawsuit. Onyx sued Bayer in May, alleging that after the little-cancer-company-that-could had shown Bayer how to make Nexavar sorafenib, Bayer...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Thu, 01 Oct 2009 15:21:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bayer+ag.html"><![CDATA[Bayer AG]]></category>
		<category domain="http://resources.bnet.com/topic/onyx+software.html"><![CDATA[Onyx Software]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BAYR Y</category>
		<category domain="tickers">BAYR Y</category>
	</item>
	<item>
		<title><![CDATA[Sony Ericsson Jalou announced, comes with a Dolce&Gabbana limited edition]]></title>
		<link><![CDATA[http://industry.bnet.com/technology/news-analysis/sony-ericsson-jalou-dolce-gabbana/7259/]]></link>
		<description><![CDATA[That Sony Ericsson Jalou we???ve heard about last week is not a Symbian smartphone after all, but a fashionable clamshell. The Jalou was just announced by Sony Ericsson, and it looks to be the same device as the Sony Ericsson Bao, leaked not long ago. Designed for women and girls,...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Wed, 12 Aug 2009 03:43:24 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/sony+ericsson+mobile+communications.html"><![CDATA[Sony Ericsson Mobile Communications]]></category>
	</item>
	<item>
		<title><![CDATA[Onyx Suit vs. Bayer Reads Like Romance Gone Wrong: "I Want My Baby Back!"]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002248/onyx-suit-vs-bayer-reads-like-romance-gone-wrong-i-want-my-baby-back/]]></link>
		<description><![CDATA[Onyx's lawsuit against Bayer over their joint venture on cancer drug Nexavar reads like a love affair gone wrong -- complete with allegations of Bayer going behind Onyx's back, cheating on the company as it concealed its intent to steal Onyx's baby. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Wed, 20 May 2009 14:06:14 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bayer+ag.html"><![CDATA[Bayer AG]]></category>
		<category domain="http://resources.bnet.com/topic/onyx+software.html"><![CDATA[Onyx Software]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BAYR Y</category>
		<category domain="tickers">BAYR Y</category>
	</item>
	<item>
		<title><![CDATA[Onyx's $320M Bet on BTG's Anticancer Compound]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F105088-onyx-s-320m-bet-on-btg-s-anticancer-compound%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Eben Tessari submits:  BTG has granted the worldwide commercialization and development rights of BGC 945, a novel anticancer compound, to Onyx ONXX in exchange for a potential $320M.  BGC 945 is a novel compound that inhibits thymidylate synthase (TS), an enzyme involved in cell growth and division. However,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 10 Nov 2008 09:53:10 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/onyx+software.html"><![CDATA[Onyx Software]]></category>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[Cell]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/eben+tessari.html"><![CDATA[Eben Tessari]]></category>
		<category domain="http://resources.bnet.com/topic/bgc+945.html"><![CDATA[BGC 945]]></category>
		<category domain="http://resources.bnet.com/topic/eben+tessari.html"><![CDATA[Eben Tessari]]></category>
		<category domain="http://resources.bnet.com/topic/onyx+pharmaceuticals+inc..html"><![CDATA[Onyx Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ONXX</category>
		<category domain="tickers">ONXX</category>
	</item>
	<item>
		<title><![CDATA[Onyx Equities, LLC announces the sale of a 10 acre site featuring an 84,471 s/f, single-story warehouse and distribution facility at 3501 Island Avenue in Philadelphia to a real estate company]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m3601/is_40_54/ai_n26674119]]></link>
		<description><![CDATA[Onyx Equities, LLC announces the sale of a 10 acre site featuring an 84,471 s/f, single-story warehouse and distribution facility at 3501 Island Avenue in Philadelphia to a real estate company. The 84,000 s/f building at 3501 Island Avenue, formerly occupied by BOC Gases, offers 10 tailgates, one drive-in door,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 04 Jun 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/equity.html"><![CDATA[equity]]></category>
		<category domain="http://resources.bnet.com/topic/onyx+software.html"><![CDATA[Onyx Software]]></category>
		<category domain="http://resources.bnet.com/topic/real+estate.html"><![CDATA[real estate]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Zacks Bull and Bear of the Day Highlights: Onyx Pharmaceuticals, Salix Pharmaceuticals, Qiagen N.V., Magellan Midstream Partners and VeriFone Holdings]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_8/ai_n25398818]]></link>
		<description><![CDATA[CHICAGO -- Zacks Equity Research highlights Onyx Pharmaceuticals (Nasdaq: ONXX) as the Bull of the Day and Salix Pharmaceuticals (Nasdaq: SLXP) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Qiagen N.V. (Nasdaq: QGEN), Magellan Midstream Partners (NYSE: MMP) and VeriFone Holdings, Inc. (NYSE: PAY)....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 08 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[analysis]]></category>
		<category domain="http://resources.bnet.com/topic/bull.html"><![CDATA[Bull]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://resources.bnet.com/topic/onyx+software.html"><![CDATA[Onyx Software]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/verifone+holdings.html"><![CDATA[VeriFone Holdings]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PAY</category>
		<category domain="tickers">NDAQ,PAY</category>
	</item>
	<item>
		<title><![CDATA[Tinton Falls OKs Onyx medical uses]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m3601/is_30_54/ai_n25128155]]></link>
		<description><![CDATA[Onyx Equities, LLC, received approval from the Tinton Falls Planning Board to lease 100% of its two existing office buildings located at 766 Shrewsbury Avenue in Tinton Falls, New Jersey, to medical tenants.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 26 Mar 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/onyx+software.html"><![CDATA[Onyx Software]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Onyx Restoration Works, a division of Alliance Building Services, recently honored employees, Bejram Qerimaj and Lee Neou, as it's 2007 Employees of the Year ceremony]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m3601/is_25_54/ai_n24359105]]></link>
		<description><![CDATA[[ILLUSTRATION OMITTED]]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 20 Feb 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/alliance.html"><![CDATA[alliance]]></category>
		<category domain="http://resources.bnet.com/topic/onyx+software.html"><![CDATA[Onyx Software]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Zacks Analyst Interview Highlights: Onyx Pharmaceuticals, ZymoGenetics, Eurand N.V., Myriad Genetics and BioMarin]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Jan_25/ai_n24224222]]></link>
		<description><![CDATA[CHICAGO -- Zacks.com releases the latest Analyst Interview. Today's interview is with senior analyst Grant Zeng, who discusses Onyx Pharmaceuticals (Nasdaq: ONXX), ZymoGenetics Inc. (Nasdaq: ZGEN), Eurand N.V. (Nasdaq: EURX), Myriad Genetics (Nasdaq: MYGN) and BioMarin Pharmaceuticals, Inc. (Nasdaq: BMRN).  A synopsis of today's Analyst Interview is presented below....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 25 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/onyx+software.html"><![CDATA[Onyx Software]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
</channel>
</rss>
